Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
National Medical Care Co (SAU:4005) Forward PE Ratio Explanation
The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.
Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .
National Medical Care Co Forward PE Ratio Related Terms
National Medical Care Co Forward PE Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
National Medical Care Co Forward PE Ratio Chart
National Medical Care Co Annual Data
Trend
2024-12
2025-12
Forward PE Ratio
22.63
16.94
National Medical Care Co Quarterly Data
2024-12
2025-03
2025-06
2025-09
2025-12
2026-03
Forward PE Ratio
22.63
22.15
22.89
19.16
16.94
16.61
SAU:4005 vs HCA, THC, EHC: Forward PE Ratio Comparison
For the Medical Care Facilities subindustry, National Medical Care Co's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
National Medical Care Co Forward PE Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, National Medical Care Co's Forward PE Ratio distribution charts can be found below:
* The bar in red indicates where National Medical Care Co's Forward PE Ratio falls into.
National Medical Care Co Forward PE Ratio Calculation
It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.
National Medical Care Co (SAU:4005) has a Forward PE Ratio of 16.43 as of Sep. 11, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on National Medical Care Co and its competitors. According to the industry distribution chart, National Medical Care Co ranks #156 out of 317 companies in the Healthcare Providers & Services industry, placing it in the top 49.2%.
Is National Medical Care Co's Forward PE Ratio too high?
National Medical Care Co's current Forward PE Ratio is 16.43. The Healthcare Providers & Services industry median Forward PE Ratio is 16.61. National Medical Care Co's value of 16.43 is 1.1% below this industry median. Based on the distribution chart, National Medical Care Co ranks #156 out of 317 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, National Medical Care Co has a GF Score™ of 93/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does National Medical Care Co's Forward PE Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, National Medical Care Co ranks #156 out of 317 companies for Forward PE Ratio. This puts National Medical Care Co in the upper half of its industry. The industry median Forward PE Ratio is 16.61. National Medical Care Co's value of 16.43 is 1.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Healthcare Providers & Services company?
The median Forward PE Ratio among Healthcare Providers & Services companies is 16.61, based on 317 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. National Medical Care Co's current Forward PE Ratio of 16.43 is 1.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on National Medical Care Co and its competitors. For the Healthcare Providers & Services industry, the median Forward PE Ratio is 16.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. National Medical Care Co's current Forward PE Ratio is 16.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is National Medical Care Co stock overvalued right now?
Based on GuruFocus' analysis, National Medical Care Co (SAU:4005) is currently considered Possible Value Trap. The stock's GF Value™ is ﷼208.38, compared to a current price of ﷼118.90 — trading 42.9% below its estimated fair value. The current Forward PE Ratio is 16.43 and 1.1% below the Healthcare Providers & Services industry median of 16.61. National Medical Care Co's overall GF Score™ is 93/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For National Medical Care Co (SAU:4005), the current Forward PE Ratio is 16.43 as of Sep. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is National Medical Care Co (SAU:4005) Overvalued in 2026?
Based on GuruFocus' analysis, National Medical Care Co stock appears to be undervalued.
The current stock price of ﷼118.90 is trading 42.9% below its estimated GF Value™ of ﷼208.38.
GuruFocus considers National Medical Care Co to be Possible Value Trap.
Key valuation signals for SAU:4005:
Forward PE Ratio: 16.43
GF Value™: ﷼208.38 vs. price of ﷼118.90 (42.9% below fair value)
Industry Position: 1.1% below the Healthcare Providers & Services median (#156 of 317)
No single metric tells the full story. See the SAU:4005 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
National Medical Care Co is engaged in the business to establish, own, equip, manage, maintain, and operate healthcare facilities and provide home health care services. The company trades medicines, medical equipment, and supplies in wholesale and retail trade. Geographically, all operations are conducted in the Kingdom of Saudi Arabia. The company generates revenue through the Rendering of clinical services, and the Sale of pharmaceuticals.
93GF Score
Get the complete analysis for SAU:4005
Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:4005 has been successfully added to your 
